Trials / Conditions / Primary Immunodeficiency (PID)
Primary Immunodeficiency (PID)
6 registered clinical trials studyying Primary Immunodeficiency (PID) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355 | Paul Szabolcs | — |
| Completed | Gammanorm Quality of Life Study in Immunodeficient Patients Using Rapid Push or Pumps NCT02180763 | Octapharma | Phase 4 |
| Recruiting | Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT NCT01962415 | Paul Szabolcs | Phase 2 |
| Completed | Assessment of Immunoglobulins (IgG) in a Long-term Non-interventional Study NCT01287689 | Technische Universität Dresden | — |
| Completed | Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study) NCT00751621 | CSL Behring | Phase 3 |
| Completed | Subcutaneous Ig NextGen 16% in PID Patients NCT00391131 | CSL Limited | Phase 3 |